Recommended
Recommended
Recent Quotes
My Watchlist
Indicators
Local Stocks
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Accolade Inc (NQ: ACCD )

3.700 -0.010 (-0.27%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,337,798
Open 3.700
Bid (Size) 3.590 (4)
Ask (Size) 3.780 (8)
Prev. Close 3.710
Today's Range 3.670 - 3.775
52wk Range 3.080 - 15.36
Shares Outstanding 76,232,192
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Forecasting The Future: 6 Analyst Projections For Accolade
Via Benzinga
Accolade's Q2 Boost: Revenue Rises, Losses Shrink, And Profitability Looms
Accolade stock up after beating Q2 2025 revenue and EPS estimates, expecting full year Adjusted EBITDA profitability and positive cash flow. 
Via Benzinga

Performance

YTD
-69.45%
-69.45%
1 Month
+15.99%
+15.99%
3 Month
-16.10%
-16.10%
6 Month
-51.63%
-51.63%
1 Year
-54.49%
-54.49%

More News

Read More
Accolade Announces Results for Fiscal Second Quarter 2025
From Accolade, Inc.
Via GlobeNewswire
Dow Dips Around 400 Points As Treasury Yields Top 4%: Investor Optimism Declines, But Fear Index Remains In 'Greed' Zone
Via Benzinga
Topics Stocks
Exposures US Equities
PepsiCo, MEDIROM Healthcare Technologies And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
Uncovering Potential: Accolade's Earnings Preview
Via Benzinga
Top Wall Street Forecasters Revamp Accolade Price Expectations Ahead Of Q2 Earnings
Via Benzinga
Accolade Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Accolade, Inc. (ACCD) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Accolade, Inc. (ACCD) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Apple To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
Nike, Accolade And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
ACCD Investors Have the Opportunity to Join Accolade, Inc. Securities Fraud Investigation with The Schall Law Firm
From The Schall Law Firm
Via Business Wire
ACCD Stock Earnings: Accolade Beats EPS, Beats Revenue for Q1 2025
Via InvestorPlace
Accolade Stock Tumbles On Q1 Earnings, Weak Guidance: What You Need To Know
Via Benzinga
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Via The Motley Fool
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
ACCD Stock Earnings: Accolade Misses EPS, Beats Revenue for Q4 2024
Via InvestorPlace
Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2024
From Accolade, Inc.
Via GlobeNewswire
Alphabet To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Alabama’s Fertility Ruling Raises Challenges for Stocks of Fertility Benefits Providers
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.